Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: Current state and problems

Journal of Cellular Biochemistry

Volumn 109, Issue 2, 2010, Pages 292-301

  Hwang, Dong Youn ^a,b   Kim, Dae Sung ^a,c   Kim, Dong Wook ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Dopamine neuron differentiation; Human ES IPS cells; Pakinson's disease

Indexed keywords

CANCER PREVENTION; CARCINOGENESIS; CELL SURVIVAL; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; GRAFT REJECTION; HUMAN; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DOPAMINE; EMBRYONIC STEM CELLS; GENETIC ENGINEERING; GRAFT REJECTION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NEURONS; PARKINSON DISEASE; RATS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

IPS;

EID: 74949118218     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22411     Document Type: Review

References (70)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boue S, Izpisua Belmonte JC. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat biotechnol 26:1276-1284.
2. Agid Y. 1991. Parkinson's disease: Pathophysiology. Lancet 337:1321-1324.
3. Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR. 2009. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease. Brain Res 1276:39-49.
4. Apostolides C, Sanford E, Hong M, Mendez I. 1998. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:363-372.
5. Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, Itzik A, Reubinoff BE. 2004. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem cells (Dayton, Ohio) 22:1246-1255.
6. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455.
7. Brundin P, Strecker RE, Lindvall O, Isacson O, Nilsson OG, Barbin G, Prochiantz A, Forni C, Nieoullon A, Widner H, Gage FH, Björklund A. 1987. Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann NY Acad Sci 495:473-496.
8. Buytaert-Hoefen KA, Alvarez E, Freed CR. 2004. Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells (Dayton, Ohio) 22:669-674.
9. Carlsson T, Carta M, Winkler C, Bjorklund A, Kirik D. 2007. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J Neurosci 27:8011-8022.
10. Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. 2001. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172:383-397.
11. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27:275-280.
12. Cho MS, Lee YE, Kim JY, Chung S, Cho YH, Kim DS, Kang SM, Lee H, Kim MH, Kim JH, Leem JW, Oh SK, Choi YM, Hwang DY, Chang JW, Kim DW. 2008. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 105:3392-3397.
13. Correia AS, Anisimov SV, Roybon L, Li JY, Brundin P. 2007. Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells. Front Neuroanat 1:4.
14. Ehringer H, Hornykiewicz O. 1960. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klinische Wochenschrift 38:1236-1239.
15. Espejo M, Cutillas B, Arenas TE, Ambrosio S. 2000. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant 9:45-53.
16. Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Kriek E, Qi JX, Lone T, Zhang YB, Snyder JA, Wells TH, Ramig L, Thompson JC, Mazziotta S, Huang ST, Grafton D, Brooks G, Sawle G, Schroter G, Ansari AA. 1992. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555.
17. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719.
18. Friling S, Andersson E, Thompson LH, Jönsson ME, Hebsgaard JB, Nanou E, Alekseenko Z, Marklund U, Kjellander S, Volakakis N, Hovatta O, El Manira A, Björklund A, Perlmann T, Ericson J. 2009. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA 106:7613-7618.
19. Geeta R, Ramnath RL, Rao HS, Chandra V. 2008. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochem Biophys Res Commun 373:258-264.
20. Gerrard L, Rodgers L, Cui W. 2005. Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells (Dayton, Ohio) 23:1234-1241.
21. Goetz AK, Scheffler B, Chen HX, Wang S, Suslov O, Xiang H, Brustle O, Roper SN, Steindler DA. 2006. Temporally restricted substrate interactions direct fate and specification of neural precursors derived from embryonic stem cells. Proc Natl Acad Sci USA 103:11063-11068.
22. Hagell P, Brundin P. 2001. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 60:741-752.
23. Hayashi H, Morizane A, Koyanagi M, Ono Y, Sasai Y, Hashimoto N, Takahashi J. 2008. Meningeal cells induce dopaminergic neurons from embryonic stem cells. Eur J Neurosci 27:261-268.
24. Hedlund E, Pruszak J, Lardaro T, Ludwig W, Vinuela A, Kim KS, Isacson O. 2008. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells (Dayton, Ohio) 26:1526-1536.
25. Hoglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J. 2001. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease. Exp Neurol 167:148-157.
26. Iacovitti L, Donaldson AE, Marshall CE, Suon S, Yang M. 2007. A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo. Brain Res 1127:19-25.
27. Jonsson ME, Ono Y, Bjorklund A, Thompson LH. 2009. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp Neurol 219:341-354.
28. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. 2000. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40.
29. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS. 2009. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-476.
30. Ko JY, Park CH, Koh HC, Cho YH, Kyhm JH, Kim YS, Lee I, Lee YS, Lee SH. 2007. Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons. J Neurochem 103:1417-1429.
31. Ko JY, Lee HS, Park CH, Koh HC, Lee YS, Lee SH. 2009. Conditions for tumorfree and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells. Mol Ther 17:1761-1770.
32. Lang AE, Lozano AM. 1998. Parkinson's disease. First of two parts. N Engl J Med 339:1044-1053.
33. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. 2000. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18:675-679.
34. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. 1998. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339:1105-1111.
35. Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA. 2006. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185-187.
36. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, Newman AH, Cha JH, Gether U, Wang H, Abeliovich A. 2006. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA 103:2874-2879.
37. Mendez I, Vinuela A, Astradsson A, Mukhida K, Hallett P, Robertson H, Tierney T, Holness R, Dagher A, Trojanowski JQ, Isacson O. 2008. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 14:507-509.
38. Olanow CW. 2004. The scientific basis for the current treatment of Parkinson's disease. Annu Rev Med 55:41-60.
39. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. 2003. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54:403-414.
40. Park S, Lee KS, Lee YJ, et al. 2004. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci Lett 359:99-103.
41. Park CH, Minn YK, Lee JY, Choi DH, Chang MY, Shim JW, Ko JY, Koh HC, Kang MJ, Kang JS, Rhie DJ, Lee YS, Son H, Moon SY, Kim KS, Lee SH. 2005. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 92:1265-1276.
42. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. 2008. Disease-specific induced pluripotent stem cells. Cell 134:877-886.
43. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, Studer L. 2004. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 101:12543-12548.
44. Piccini P, Brooks DJ, Bjorklund A, Gunn RN, Grasby PM, Rimoldi O, Brundin P, Hagell P, Rehncrona S, Widner H, Lindvall O. 1999. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2:1137-1140.
45. Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, Itzik A, Ben-Hur T. 2001. Neural progenitors from human embryonic stem cells. Nat Biotechnol 19:1134-1140.
46. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. 2006. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12:1259-1268.
47. Schmandt T, Meents E, Gossrau G, Gornik V, Okabe S, Brustle O. 2005. Highpurity lineage selection of embryonic stem cell-derived neurons. Stem Cells Dev 14:55-64.
48. Schulz TC, Noggle SA, Palmarini GM, Weiler DA, Lyons IG, Pensa KA, Meedeniya AC, Davidson BP, Lambert NA, Condie BG. 2004. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells (Dayton, Ohio) 22:1218-1238.
49. Shimada H, Yoshimura N, Tsuji A, Kunisada T. 2009. Differentiation of dopaminergic neurons from human embryonic stem cells: Modulation of differentiation by FGF-20. J Biosci Bioeng 107:447-454.
50. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R. 2009. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136:964-977.
51. Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, Isacson O. 2007. Enhanced yield of neuroepithelial precursors and midbrainlike dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells (Dayton, Ohio) 25:411-418.
52. Sortwell CE. 2003. Strategies for the augmentation of grafted dopamine neuron survival. Front Biosci 8:s522-s532.
53. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, Wu JC. 2009. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106:15720-15725.
54. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
55. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
56. Thompson LH, Andersson E, Jensen JB, Barraud P, Guillemot F, Parmar M, Bjorklund A. 2006. Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon. Exp Neurol 198:183-198.
57. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science (New York, NY) 282:1145-1147.
58. Twelves D, Perkins KS, Counsell C. 2003. Systematic review of incidence studies of Parkinson's disease. Mov Disord 18:19-31.
59. Ueno M, Matsumura M, Watanabe K, Nakamura T, Osakada F, Takahashi M, Kawasaki H, Kinoshita S, Sasai Y. 2006. Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix. Proc Natl Acad Sci USA 103:9554-9559.
60. Umemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH. 2003. Deep brain stimulation for movement disorders: Morbidity and mortality in 109 patients. J Neurosurg 98:779-784.
61. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, Hochedlinger K. 2009. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460:1145-1148.
62. Volkmann J, Sturm V, Weiss P, Kappler J, Voges J, Koulousakis A, Lehrke R, Hefter H, Freund HJ. 1998. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Ann Neurol 44:953-961.
63. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle G, Björklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O. 1997. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 42:95-107.
64. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 105:5856-5861.
65. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK. 2001. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971-974.
66. Yan Y, Yang D, Zarnowska ED, Du Z, Werbel B, Valliere C, Pearce RA, Thomson JA, Zhang SC. 2005. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells (Dayton, Ohio) 23:781-790.
67. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science (New York, NY) 324:797-801.
68. Zeng X, Cai J, Chen J, Luo Y, You ZB, Fotter E, Wang Y, Harvey B, Miura T, Backman C, Chen GJ, Rao MS, Freed WJ. 2004. Dopaminergic differentiation of human embryonic stem cells. Stem Cells (Dayton, Ohio) 22:925-940.
69. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. 2001. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129-1133.
70. Zhou W, Lee YM, Guy VC, Freed CR. 2009. Embryonic stem cells with GFP knocked into the dopamine transporter yield purified dopamine neurons in vitro and from knock-in mice. Stem Cells (Dayton, Ohio) [Epub ahead of print].